SCHEMBL22693164

SCHEMBL22693164

Cc1ccc(NC2CCN(c3ccccc3C#N)CC2)cc1C(=O)N1CCN(c2cccc(F)c2S(N)(=O)=O)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 7/20 0.68
RPTOR Q8N122 7/20 0.68
MLST8 Q9BVC4 7/20 0.68
DRD4 P21917 2/20 0.40
DPP4 P27487 1/20 0.40
MEN1 O00255 1/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 2/20 0.39
NAMPT P43490 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
PARP1 P09874 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141306 0.89 MTOR (0.85) MTORRPTORMLST8DPP4MEN1
SCHEMBL20129696 0.88 MTOR (0.59) MTORRPTORMLST8DRD4NAMPT
SCHEMBL20129694 0.85 MTOR (0.65) MTORRPTORMLST8DPP4NAMPT
SCHEMBL20133660 0.84 MTOR (0.72) MTORRPTORMLST8DPP4MEN1
SCHEMBL20133719 0.84 MTOR (0.73) MTORRPTORMLST8DRD4DPP4
SCHEMBL20133540 0.84 MTOR (0.77) MTORRPTORMLST8DPP4MEN1
SCHEMBL22186355 0.83 MTOR (0.56) MTORRPTORMLST8DRD4MEN1
SCHEMBL20133709 0.81 MTOR (1.00) MTORRPTORMLST8DPP4TSHR
SCHEMBL20133729 0.81 MTOR (1.00) MTORRPTORMLST8DPP4TSHR
SCHEMBL22693203 0.81 MTOR (0.60) MTORRPTORMLST8DPP4NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.